Have you ever imagined what the future of heart imaging might look like? Did you ever think it would look a little like the image above? Well, it looks pretty amazing to us and it sounds as though the future of imaging might very well be upon us.
Acutus Medical, a company headquartered in Carlsbad, California, won FDA clearance for its AcQMap High Resolution Imaging and Mapping System, as well as the accompanying AcQMap 3D Imaging and Mapping Catheter.
The Catheter allows for a unique live view inside the heart by using ultrasound and more traditional electrical tissue conduction mapping. It effectively combines the physical mechanics of the organ with its electrical activity.
The device is set to be particularly appropriate for cardiac ablation procedures when monitoring the heart’s response to treatment.
In a statement, Dr. Tom Wong, from Royal Brompton Hospital in London, England said:
“We are extremely excited to have participated in the early clinical work and are now using the technology as part of a patient-specific strategy to assess and treat complex arrhythmias.”
“The AcQMap System is able to provide global dipole density mapping of irregular and chaotic activation in the atrial chambers, whereas conventional sequential mapping may struggle to provide us with the information that is required. In the cases we have performed thus far, real-time mapping of complex arrhythmias has allowed us to focus on areas of interest and terminate the arrhythmia using ablation therapy. We can now offer individualized, tailored therapy, and are one step closer to identifying the mechanisms of complex arrhythmias.”
An example of the mapping created by the AcQMap system, can be viewed in the Medgadget article, AcQMap, Now FDA Cleared, Images Heart from Inside Using Ultrasound, Electrical Dipole Density Mapping.